Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys
- PMID: 12589523
- DOI: 10.1007/s00213-002-1347-0
Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys
Abstract
Rationale: The D2-like receptor partial agonist terguride has a profile of behavioral effects in rats that suggests potential benefit as a pharmacotherapy for cocaine addiction.
Objectives: The present study investigated the effects of terguride on cocaine- and food-maintained behavior in squirrel monkeys.
Methods: Squirrel monkeys were trained to respond on a second-order schedule (FI 10 min, FR 10 or 30:S) of either i.v. cocaine injection or food pellet delivery. Additional monkeys were studied using quantitative observational techniques to construct side effect profiles. Under each procedure, the effects of terguride were compared with those of the reference D2-like receptor antagonist nemonapride and the D2-like receptor full agonist quinpirole.
Results: Terguride and nemonapride, but not quinpirole, dose-dependently reduced cocaine-maintained behavior. In animals self-administering food, terguride decreased response rates at doses lower than those required to suppress cocaine-maintained behavior. Effective doses of terguride had no systematic effect on motor activity or muscle rigidity, whereas effective doses of nemonapride virtually eliminated motor activity and induced severe catalepsy. The primary observable effects of terguride were a modest increase in self-directed behavior (a D2-receptor agonist-like effect) at intermediate doses and a small increase in static posture (a D2-receptor antagonist-like effect) at the highest dose tested.
Conclusions: The results suggest that terguride has advantages over conventional D2-like receptor antagonists and agonists as a candidate pharmacotherapy for cocaine abuse; however, terguride significantly reduces food-maintained behavior at lower doses than those needed to decrease cocaine-maintained behavior suggesting limitations on the utility of terguride as a medication for cocaine addiction.
Similar articles
-
A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.Pharmacol Biochem Behav. 2001 Apr;68(4):701-8. doi: 10.1016/s0091-3057(01)00472-5. Pharmacol Biochem Behav. 2001. PMID: 11526967
-
Discriminative stimulus effects of cocaine in squirrel monkeys: lack of antagonism by the dopamine D2 partial agonists terguride, SDZ 208-911, and SDZ 208-912.Pharmacol Biochem Behav. 1995 Aug;51(4):661-5. doi: 10.1016/0091-3057(94)00434-k. Pharmacol Biochem Behav. 1995. PMID: 7675840
-
Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats.Pharmacol Biochem Behav. 2003 Aug;76(1):27-34. doi: 10.1016/s0091-3057(03)00188-6. Pharmacol Biochem Behav. 2003. PMID: 13679214
-
Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine.Neurochem Int. 1992 Mar;20 Suppl:147S-152S. doi: 10.1016/0197-0186(92)90228-j. Neurochem Int. 1992. PMID: 1365414 Review. No abstract available.
-
BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction.CNS Drug Rev. 2003 Summer;9(2):141-58. doi: 10.1111/j.1527-3458.2003.tb00246.x. CNS Drug Rev. 2003. PMID: 12847556 Free PMC article. Review.
Cited by
-
Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Neuropharmacology. 2014 Jan;76 Pt B(0 0):301-19. doi: 10.1016/j.neuropharm.2013.08.014. Epub 2013 Aug 23. Neuropharmacology. 2014. PMID: 23973315 Free PMC article. Review.
-
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.J Pharmacol Exp Ther. 2010 Aug;334(2):556-65. doi: 10.1124/jpet.110.167619. Epub 2010 May 21. J Pharmacol Exp Ther. 2010. PMID: 20494958 Free PMC article.
-
Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.Psychopharmacology (Berl). 2008 Jul;199(1):37-46. doi: 10.1007/s00213-008-1069-z. Epub 2008 May 15. Psychopharmacology (Berl). 2008. PMID: 18481046
-
Novel approaches to the treatment of cocaine addiction.CNS Drugs. 2005;19(1):13-25. doi: 10.2165/00023210-200519010-00002. CNS Drugs. 2005. PMID: 15651902 Review.
-
Second-order stimuli do not always increase overall response rates in second-order schedules of reinforcement in the rat.Psychopharmacology (Berl). 2004 Jul;174(3):430-7. doi: 10.1007/s00213-004-1867-x. Epub 2004 Apr 9. Psychopharmacology (Berl). 2004. PMID: 15083254
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources